SEC Comment Letter for InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Sep 26, 2014

InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: Sept. 26, 2014 · CIK: 0001433607 · Accession: 0000000000-14-048485

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-35731

Date

December 31, 2013

Author

/s/ Brian Cascio

Form

UPLOAD

Company

InspireMD, Inc. (NSPR) (CIK 0001433607)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE September 26 , 2014 Via E -Mail Mr. Craig Shore Chief Financial Officer InspireMD, Inc. 321 Columbus Avenue Boston, Massachusetts 02116

Re: InspireMD, Inc. Form 10-KT for the Fiscal Year Ended December 31, 2013 Filed February 26, 2014 File No . 001-35731

Dear Mr. Shore :

We have completed our review of your filings. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filings and the company may not assert staff comments as a defense in a ny proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filings to be certain that the filings include t he information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Brian Cascio

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

September 26 , 2014

Via E -Mail
Mr. Craig Shore
Chief Financial Officer
InspireMD, Inc.
321 Columbus Avenue
Boston, Massachusetts 02116

 Re: InspireMD, Inc.
Form 10-KT for the Fiscal Year Ended  December 31, 2013
Filed February 26, 2014
File No .  001-35731

Dear Mr. Shore :

We have completed our review of your filings.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filings and the company may not assert staff
comments as a defense in a ny proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filings to be certain that the filings include t he
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

/s/ Brian Cascio

Brian Cascio
Accounting Branch Chief

SecProbe.io